Device Sports Early Intervention

Monovisc

Payments companies reported to CMS as associated with Monovisc. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$569Kassociated payments (2023-2025)

6,454clinicians with associated payments

5companies reporting

By year

2023 $155K

2024 $257K

2025 $156K

Payments reported as associated with Monovisc, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Sports Medicine (Orthopaedic Surgery) $179K

Physician Assistant $75K

Orthopaedic Surgery $71K

Surgical $69K

Hand Surgery $58K

Sports Medicine (Family Medicine) $16K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Monovisc

These are the largest totals companies reported as associated with Monovisc. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Justin Ernat	Vail, CO	Sports Medicine (Orthopaedic Surgery)	$94,331.25
Michael Redler	Trumbull, CT	Hand Surgery	$50,985.27
Terry Lin	New York, NY	Surgical	$43,406.44
James Oholleran	Peabody, MA	Sports Medicine (Orthopaedic Surgery)	$36,634.26
Calvin Abor	Abilene, TX	Physician Assistant	$28,160.82
Alan Zhang	San Francisco, CA	Sports Medicine (Orthopaedic Surgery)	$24,150.00
Jamie Lynch	San Antonio, TX	Sports Medicine (Orthopaedic Surgery)	$5,463.75
Jeanine Gargiulo	Alexandria, VA	Surgical	$4,182.77
Eric Wagner	Atlanta, GA	Hand Surgery	$3,630.00
Sara Holland	Madison, WI	Physician Assistant	$3,077.02

Prescribed Monovisc?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.